Dexamethasone iontophoretic - IOMED

Drug Profile

Dexamethasone iontophoretic - IOMED

Alternative Names: Dexametasone iontophoretic - IOMED; G-II; IontoDex; ProDex

Latest Information Update: 07 Oct 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator IOMED
  • Class Anti-inflammatories; Antiemetics; Antineoplastics; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation; Tendinitis

Most Recent Events

  • 06 Aug 2013 Biomarkers information updated
  • 07 Oct 2005 Discontinued - Phase-III for Inflammation in USA (Transdermal)
  • 07 Oct 2005 Discontinued - Phase-III for Tendinitis in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top